Fortnum, 2024 - Google Patents
Introduction to Kidney Functions and PathophysiologyFortnum, 2024
- Document ID
- 703756359578818082
- Author
- Fortnum D
- Publication year
- Publication venue
- Principles of Nursing in Kidney Care: Under the Auspices of EDTNA/ERCA and EKPF
External Links
Snippet
Healthy kidney function pathophysiology underpins all aspects of kidney disease, the complications of kidney disease and associated treatments. The nephrons are the powerhouse of the kidney performing many complex functions that enable the kidneys to …
- 230000003907 kidney function 0 title abstract description 11
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3601—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit
- A61M1/3603—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit in the same direction
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Beaumont | Evaluation of hemoconcentration from hematocrit measurements. | |
Lote et al. | Principles of renal physiology | |
Brown et al. | Aging and the kidney | |
Lindinger et al. | NaHCO3 and KHCO3 ingestion rapidly increases renal electrolyte excretion in humans | |
Chalmers | Applied anatomy and physiology and the renal disease process | |
Perinpam et al. | Key influence of sex on urine volume and osmolality | |
Kallash et al. | Mechanisms and management of edema in pediatric nephrotic syndrome | |
Friederich-Persson et al. | Increased kidney metabolism as a pathway to kidney tissue hypoxia and damage: effects of triiodothyronine and dinitrophenol in normoglycemic rats | |
Goulet et al. | Salt+ glycerol-induced hyperhydration enhances fluid retention more than salt-or glycerol-induced hyperhydration | |
Yost et al. | Efficacy of inpatient rehabilitation after left ventricular assist device implantation | |
Lins et al. | Long-term angiotensin II infusion induces oxidative and endoplasmic reticulum stress and modulates Na+ transporters through the nephron | |
Savoie et al. | Sodium-induced hyperhydration decreases urine output and improves fluid balance compared with glycerol-and water-induced hyperhydration | |
Fortnum | Introduction to Kidney Functions and Pathophysiology | |
Yang et al. | Weight-based assessment of access flow threshold to predict arteriovenous fistula functional patency | |
Macías-Núñez et al. | Physiology of the healthy aging kidney | |
Volianitis et al. | Plasma pH does not influence the cerebral metabolic ratio during maximal whole body exercise | |
Fujii et al. | Human atrial natriuretic peptide for acute kidney injury in adult critically ill patients: A multicenter prospective observational study | |
Masià-Plana et al. | Principles of Nursing in Kidney Care: Under the Auspices of EDTNA/ERCA and EKPF | |
Klahr et al. | Renal Regulation of Sodium Excretion: Function in Health and in Edema-Forming States | |
Kubo et al. | Factors delaying the progress of early rehabilitation of elderly Japanese patients with heart failure | |
Hunter et al. | Exploring heated exercise as a means of preventing the deleterious effects of high-sodium intake in Black women | |
Thornburg et al. | Acute kidney injury: Limiting the damage | |
Ridley et al. | Metabolic origins of urine and other body fluids | |
Brouhard | The role of dietary protein in progressive renal disease | |
Raja et al. | Management of the dental patient with renal disease |